Assessment of Serum Tumor Markers for Predicting Ocular Metastasis in Lung Adenocarcinoma: A Retrospective Study

Table 2

Other metastatic sites of the OM and NOM groups.

Sites	OM	NOM
Lung	18 (38.3%)	359 (32.5%)
Lymph node	28 (59.6%)	682 (61.7%)
Brain	46 (97.9%)	177 (16.0%)
Bone	27 (57.4%)	389 (35.2%)
Liver	8 (17.0%)	175 (15.8%)
Peritoneum	2 (4.3%)	137 (12.4%)
Pleura	3 (6.4%)	6 (0.5%)

OM: ocular metastasis; NOM: nonocular metastasis.